HistoIndex to debut FibroSIGHT™ Plus and showcase latest scientific findings at AASLD The Liver Meeting® 2025

The latest from the Proscia blog: Everyone’s talking about AI in therapeutic R&D, but it’s not always easy to cut through the hype to understand where it’s making a real impact today. One of the clearest signals of progress?...

Study: Lithium loss ignites Alzheimer’s, but lithium compound can reverse disease in mice What is the earliest spark that ignites the memory-robbing march of Alzheimer’s disease? Why do some people with Alzheimer’s-like changes in the...

OptraSCAN: AI-Powered Cytology Platform Expands Access and Accuracy for Cervical Cancer Screening Across Asia—Aligned with WHO’s 90-70-90 Elimination Goals SINGAPORE, August 5, 2025 /EINPresswire.com/ -- OptraSCAN, a global leader in...

EVIDENT: Expanded product offering propels digital pathology from simply creating images to generating new insights for pathologists WALTHAM, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Evident announces a definitive agreement to acquire Pramana,...

AiosynQC and IVDR-certified Aiosyn Mitosis Breast are now available through Pathomation’s AI Marketplace, building on their AWAKE project collaboration to transform kidney diagnostics with AI. Antwerp, Belgium, and Nijmegen, Netherlands...

ROCHESTER, Minn. — Mayo Clinic took a pivotal step toward integrating AI solutions in the clinical setting with the deployment of NVIDIA DGX SuperPOD with NVIDIA DGX B200 systems, an advanced infrastructure that provides state-of-the-art...